SCHEMBL30007741

SCHEMBL30007741

CS(=O)(=O)c1ccc(-c2cnc3[nH]c(C(=O)N4CCC(c5ccccc5)CC4)cc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
EPHX2 P34913 2/20 0.43
EPHX1 P07099 1/20 0.43
KCNH2 Q12809 1/20 0.43
HTR2B P41595 2/20 0.41
KDM4C Q9H3R0 1/20 0.41
FASN P49327 2/20 0.41
HRH4 Q9H3N8 2/20 0.41
HRH3 Q9Y5N1 1/20 0.41
SCD5 Q86SK9 3/20 0.41
SCD O00767 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
SPR P35270 1/20 0.40
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30008315 0.81 HRH4 (0.49) HRH4HRH3TACR3
SCHEMBL30007265 0.81 AVPR1A (0.49) CA12CA1CA2CA7CA9
SCHEMBL30007560 0.81 CA12 (0.43) CA12CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL30008041 0.77 CDK5 (0.44) KCNH2SCD
SCHEMBL30008202 0.72 KMT2A (0.47) CA1CA2CA7CA9CA14
SCHEMBL30007738 0.72 KDM5A (0.42) CA12CA1CA2CA7CA9
SCHEMBL30007554 0.72 AVPR1A (0.47) CA12CA1CA2CA7CA9
SCHEMBL27306947 0.70 AKR1C3 (0.66) HRH4HRH3
SCHEMBL22777821 0.68 AXL (0.50)
SCHEMBL23147464 0.67 AXL (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed